Clinical trial Recruiting at 1 site Interventional Ages 45 to 75

Close vs. Open chain exercises with blood flow restriction for knee osteoarthritis

Official title: Comparison of Close Chain and Open Chain Exercises With Blood Flow Restriction in Knee Osteoarthritis

Run by Riphah International University · NCT07426549 · Data updated 2026-11-12

This trial tests whether close-chain exercises with blood flow restriction or open-chain exercises with blood flow restriction help reduce knee pain and improve motion, strength, and function in adults with knee osteoarthritis.

Quick facts

Study typeInterventional
Ages45 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorRiphah International University
Academic / other
Locations2 sites (Rawalpindi and 1 other locations)
StatusRecruiting
StartedJune 30, 2026
Main results expectedOctober 30, 2026
Study endsNovember 7, 2026
Registry record updatedJuly 20, 2026
Trial IDNCT07426549 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 45-75 with radiographic KOA grade 1 or 2, unilateral symptoms, not currently receiving KOA therapies, and without contraindicating medical conditions.

Probably not a fit

Participants with knee conditions outside KOA grade 1-2, bilateral KOA, recent knee surgery, uncontrolled blood pressure, or contraindications to blood flow restriction may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two exercise approaches that use blood flow restriction in adults with mild knee osteoarthritis. Participants are 45-75 years old with Kellgren-Lawrence grade 1 or 2 KOA and are assigned to either closed kinetic chain or open kinetic chain exercises, both with blood flow restriction, over four weeks. Outcomes include pain, range of motion, muscle strength, and functional performance measured by NPRS, WOMAC, goniometer, dynamometer, and a chair stand test. The study is conducted at two Rawalpindi centers with 40 participants and uses SPSS for data analysis.

Why it matters

Potential benefit: If successful, patients might experience less pain and better knee function with a targeted, blood flow–restricted exercise program.

How similar studies have gone: Similar approaches with blood flow restriction have shown promise in improving pain and function in knee OA, though results vary and larger trials are needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Radiologic confirmation of KOA demonstrating Kellgren-Lawrence grade 1 or 2.
* Exhibited symptoms of unilateral KOA.
* Not taking any medications for KOA or receiving other treatments (including physiotherapy).
* Willing to participate without any neurological symptoms were the main objects of study.

Exclusion Criteria:

* A history of knee surgery or scheduled surgery.
* Kellgren-Lawrence grade 3 or 4.
* Systolic blood pressure over 160 mm Hg or under 100 mm Hg.
* Use of nonsteroidal anti-inflammatory drugs in the past 3 months.
* Any known vascular disease or any diagnosed blood pathology.
* Concomitant symptomatic hip or ankle pathology that could influence knee pain or function.

Where it's running

  • Medistic Medical and Dental Center
    Rawalpindi, Pakistan
    Recruiting
  • Pakistan Railway General Hospital
    Rawalpindi, Pakistan
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.